Search by Ticker
Gw Pharmaceuticals Plc (NasdaqGM:GWPH)
The following stock analysis is based on 7.3 years of data (i.e. since May 01, 2013). All the stock history has been downloaded.
Gw Pharmaceuticals Plc trades on the NasdaqGM exchange in USD dollars.
It is in the healthcare sector.
It is currently trading at $109.8 ($113.95 the previous day).
The next reporting date is in 90 days (2020 11 10).
The current Canada / US exchange rate is 1.3296.
Over the past 12 months, $48960 worth of shares have been purchased and $26961061 worth of shares have been sold by insiders.
The year over year average increase is 0.4% per year assuming steady exponential growth. The actual 5 year average is 7.1. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||115.81474777778||-23||- Below Average|
|2 year||150.33126666667||17.6||+ Above Average|
|3 year||127.87903361345||11.6||+ Above Average|
|4 year||114.6093902439||42.7||+ Above Average|
|5 year||80.313660377359||-13.4||- Below Average|
The worst drop it has had in recent years is -71.7%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.
GW Pharma shares slide 12% after company swings to loss during pandemicFri, 07 Aug 2020 15:24:00 Shares of GW Pharmaceuticals PLC slumped 12% Friday, after the company swung to a loss in the second quarter, hurt by the effect of the coronavirus pandemic. The U.K. company is the only one to have U.S. Food and ...... Read Full Article
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOsFri, 07 Aug 2020 11:34:07 Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 6) * ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction of AditxtScore for COVID-19 to be used in detecting antibodies against SARS-CoV-2 antigens) * Axonics Modulation Technologies Inc (NASDAQ: AXNX) * Biocept Inc (NASDAQ: BIOC) (announced ...... Read Full Article
GW Pharmaceuticals: Q3 Earnings InsightsThu, 06 Aug 2020 20:44:27 Shares of GW Pharmaceuticals (NASDAQ:GWPH) increased 13.41% in after-market trading after the company reported Q3 results.Quarterly Results Earnings per share were up 66.67% year over year to ($0.02), which beat the estimate of ($0.63).Revenue of $121,297,000 higher by 68.38% from the same period ...... Read Full Article
GW Pharmaceuticals plc Reports Second Quarter 2020 Financial Results and Operational ProgressThu, 06 Aug 2020 20:00:00 and#92;- Total revenue increased 68 percent to $121.3 million - and#92;- Epidiolex approved in the U.S. for seizures associated with TSC, launch expected this month - and#92;- Conference call today at 4:30 p.m. EDT –LONDON and CARLSBAD, Calif., ...... Read Full Article
Why GW Pharmaceuticals Stock Is Up TodayMon, 03 Aug 2020 19:45:00 Shares of GW Pharmaceuticals (NASDAQ: GWPH) are up by 4.8% as of 3:18 p.m. EDT on Monday, after rising by as much as 5.5% earlier in the day. The catalyst for these nice gains is the fact that the U.S. Food ...... Read Full Article
GW Pharmaceuticalsand' Epidiolex Wins New FDA ApprovalsMon, 03 Aug 2020 19:36:00 The companyand's star CBD drug can now be prescribed for a new condition, and its age range for a previous approval has been expanded.... Read Full Article
GW Pharmaand's stock rallies after its cannabinoid drug gets a new FDA approvalMon, 03 Aug 2020 18:05:00 Shares of GW Pharmaceuticals rallied 5.0% in trading on Monday after the drugmaker said its cannabinoid drug Epidiolex had received approval from the Food and Drug Administration for a new indication. The drug, which is the first cannabinoid-based treatment to receive ...... Read Full Article
Did Hedge Funds Make The Right Call On GW Pharmaceuticals plc (GWPH) ?Mon, 03 Aug 2020 17:01:20 Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge fundsand' and successful investorsand' positions as of the end of the ...... Read Full Article
FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis ComplexMon, 03 Aug 2020 11:00:00 – Age-range for all EPIDIOLEX indications expanded to include patients one year of age and older –– Third indication approved for EPIDIOLEX, the only FDA-approved Cannabidiol (CBD) medicine – CARLSBAD, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader ...... Read Full Article
GW Pharma Scores New FDA Approval For CBD Drug EpidiolexMon, 03 Aug 2020 05:29:18 Cannabis stock GW Pharma (GWPH) has announced that the US Food and Drug Administration (FDA) has approved Epidiolex oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.This ...... Read Full Article
Should Investors Buy GW Pharma Stock Right Now?Sun, 02 Aug 2020 13:34:00 Although GW Pharma (NASDAQ: GWPH) might not be a pot stock in the traditional sense, sales of the company's cannabidiol (CBD)-based drug, Epidiolex, have been growing at an impressive rate. With the company's second CBD-based drug, Nabiximols, set to ...... Read Full Article
Top Marijuana Stocks on the NASDAQ for August 2020Thu, 30 Jul 2020 17:58:44 These are the marijuana stocks on the nasdaq stocks with the best value, fastest growth, and best performance for August.... Read Full Article
Will Epidolex Drive GW Pharmaceuticalsand' (GWPH) Q2 Earnings?Thu, 30 Jul 2020 15:53:03 Amid the pandemic situation, GW Pharmaceuticals (GWPH), which controls its own manufacture and supply chain, is expected to have faced minimum supply-related disruption unlike others.... Read Full Article
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer EarningsSun, 26 Jul 2020 13:54:59 Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. (NASDAQ: NVAX) and Moderna Inc (NASDAQ: ...... Read Full Article
2 Top Pot Stocks to Buy in a RecessionSun, 26 Jul 2020 12:10:00 In a recession, deciding on which stocks to hold in your portfolio can be a challenging task. You need to look for companies that sell products and services that will continue to be in demand during a recession and that ...... Read Full Article
3 Biotech Stocks With Big Incoming CatalystsSat, 25 Jul 2020 10:56:00 Biotech investors can get ready for a busy month full of stock-moving binary events. All of these companies are waiting for the FDA to make some very important approval decisions. Here's what you should know about three of the most ...... Read Full Article
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Second Quarter Ending June 30th, 2020 and Host Conference Call on August 6th, 2020Thu, 23 Jul 2020 11:00:00 LONDON and CARLSBAD, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on August 6th, 2020 its ...... Read Full Article
FDA releases guidelines for cannabis-related research, but CBD will have to waitTue, 21 Jul 2020 19:09:00 The U.S. Food and Drug Administration released preliminary guidance on Tuesday on cannabis-related clinical research, outlining how companies seeking approval of drugs that contain cannabis or its derivatives must follow the traditional drug review and approval process involving clinical ...... Read Full Article
Better Buy: GW Pharmaceuticals vs. Corbus PharmaceuticalsFri, 17 Jul 2020 20:21:00 Medical marijuana is known to have helped with many health issues and has even worked better than conventional medicines in some cases. Both Cambridge, U.K.-based GW Pharmaceuticals (NASDAQ: GWPH) and Massachusetts, U.S.-based Corbus Pharmaceuticals Holdings' (NASDAQ: ...... Read Full Article
Doctors Ethan Russo And Dale Hunt Join Robert Clarke To Launch Cannabis IP-Licensing FirmFri, 17 Jul 2020 16:27:29 Lawyer and plant scientist Dale Hunt, leading cannabis researcher Ethan Russo, and botanist Robert Clarke have joined forces to launch Breederand's Best.The company will be focused on intellectual property licensing within the cannabis industry.Breederand's Best helps cannabis breeders ...... Read Full Article